These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6496186)

  • 1. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays.
    Holm HA; Abildgaard U; Kalvenes S; Anderssen N; Anker E; Arnesen KE; Blikom D; Drivenes A
    Acta Med Scand; 1984; 216(3):287-93. PubMed ID: 6496186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding.
    Holm HA; Abildgaard U; Kalvenes S
    Thromb Haemost; 1985 Apr; 53(2):278-81. PubMed ID: 4024037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin treatment of deep venous thrombosis in 280 patients: symptoms related to dosage.
    Holm HA; Finnanger B; Hartmann A; Laerum F; Løhren O; Ruud TE; Stray N; Wolland T
    Acta Med Scand; 1984; 215(1):47-53. PubMed ID: 6695563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase therapy in the routine management of deep venous thrombosis in the lower extremities. A retrospective study of phlebographic results and therapeutic complications.
    Ott P; Eldrup E; Oxholm P; Vestergård A; Knudsen JB
    Acta Med Scand; 1986; 219(3):295-300. PubMed ID: 3706003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study].
    Faivre R; Neuhart Y; Kieffer Y; Apfel F; Magnin D; Didier D; Toulemonde F; Bassand JP; Maurat JP
    Presse Med; 1988 Feb; 17(5):197-200. PubMed ID: 2965375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222).
    Janvier G; Winnock S; Dugrais G; Vallet A; Dardel E; Serisé JM; Calen S; Vergnes C; Toulemonde F
    Haemostasis; 1987; 17(1-2):49-58. PubMed ID: 3596357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis.
    Moser KM; Fedullo PF; LitteJohn JK; Crawford R
    JAMA; 1994 Jan; 271(3):223-5. PubMed ID: 8277550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin or thrombolysis in the treatment of deep venous thrombosis of the leg].
    Widmer LK; Madar G; Schmitt HE; Duckert F; da Silva MA; Müller G
    Vasa; 1974; 3(4):422-32. PubMed ID: 4613050
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study.
    Thromb Haemost; 1991 Mar; 65(3):251-6. PubMed ID: 1646490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin kinetics in venous thrombosis and pulmonary embolism.
    Hirsh J; van Aken WG; Gallus AS; Dollery CT; Cade JF; Yung WL
    Circulation; 1976 Apr; 53(4):691-5. PubMed ID: 1253392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent pulmonary embolism. A prospective study.
    Monreal M; Ruiz J; Salvador R; Morera J; Arias A
    Chest; 1989 May; 95(5):976-9. PubMed ID: 2707089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.
    Hirsh J
    Am Heart J; 1992 Apr; 123(4 Pt 2):1115-22. PubMed ID: 1553881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thrombosis and pulmonary embolism.
    Wessler S
    Hosp Pract (Off Ed); 1987 Dec; 22(12):159-72, 177-8, 181. PubMed ID: 3119636
    [No Abstract]   [Full Text] [Related]  

  • 20. [Re-permeation of deep venous thrombosis of the lower extremities: comparison between plethysmographic indices and phlebography scores. Preliminary results].
    Bachet P; Ninet J; Guillaume A; Fournet D; Pasquier J
    J Mal Vasc; 1987; 12(2):168-74. PubMed ID: 3585187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.